Actemra Actpen

Common Brands Actos
Drug Class
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Prescription only
Allison Barnes, PharmD
Allison Barnes, PharmD
Read More
Medically reviewed by Allison Barnes, PharmD last update on 20/12/2023


Actemra Actpen stands as a pivotal advancement in the realm of inflammatory disease management, emerging as a potent and versatile injectable medication. Tocilizumab, its active ingredient, is a humanized monoclonal antibody meticulously designed to target the interleukin-6 (IL-6) receptor. This mechanism of action sets Actemra Actpen apart, offering a focused approach to mitigating inflammation in various conditions.

Actemra Actpen finds application in treating a spectrum of inflammatory disorders, notably rheumatoid arthritis, juvenile idiopathic arthritis, giant cell arteritis, and cytokine release syndrome. Its versatile nature allows healthcare professionals to tailor treatment plans, addressing the unique needs of each patient.



Prescription only

Pregnancy & Lactation